Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis

被引:15
作者
Bowlus, Christopher L.
Karlsen, Tom H.
Broome, Ulrika
Thorsby, Erik
Vatn, Morten
Schrumpf, Erik
Lie, Benedicte A.
Boberg, Kirsten Muri [1 ]
机构
[1] Univ Hosp Oslo, Rikshosp, Dept Med, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
[3] Univ Calif Davis, Med Ctr, Div Gastroenterol, Sacramento, CA 95817 USA
[4] Univ Hosp Oslo, Rikshosp, Inst Immunol, Oslo, Norway
[5] Huddinge Univ Hosp, Dept Gastroenterol & Hepatol, Stockholm, Sweden
关键词
primary sclerosing cholangitis; genetics; mucosal addressin cellular adhesion molecule-1; intercellular adhesion molecule-1; inflammatory bowel disease; cholangiocarcinoma; human leukocyte antigen;
D O I
10.1016/j.jhep.2006.03.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims:Mucosal addressin cellular adhesion molecule-1 (MAdCAM-1) has been implicated in the aberrant homing of intestinal lymphocytes to the liver in primary sclerosing cholangitis (PSC). Intercellular adhesion molecule-1 (ICAM-1) has also been implicated in the pathogenesis of PSC and the E/E genotype of the K469E polymorphism has been reported to be associated with PSC susceptibility. The aims of this study were to determine if MAdCAM-l polymorphisms or the K469E polymorphism of ICAM-1 are associated with PSC in Scandinavia. Results: No significant association with PSC was found for any of the MAdCAM-1 or ICAM-1 SNPs. Allele frequencies for these polymorphisms were not significantly different between PSC patients with UC, UC patients and healthy controls. Conclusions: Polymorphisms in MAdCAM-1 are not likely to significantly affect PSC susceptibility. In addition, the E/E genotype of the K469E in ICAM-1 does not influence PSC susceptibility in Scandinavia. (c) 2006 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:704 / 710
页数:7
相关论文
共 43 条
[1]  
ADAMS DH, 1991, HEPATOLOGY, V14, P426, DOI 10.1002/hep.1840140305
[2]   Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community [J].
Bambha, K ;
Kim, WR ;
Talwalkar, J ;
Torgerson, H ;
Benson, JT ;
Therneau, TM ;
Loftus, EV ;
Yawn, BP ;
Dickson, ER ;
Melton, LJ .
GASTROENTEROLOGY, 2003, 125 (05) :1364-1369
[3]   Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel [J].
Barker, DL ;
Hansen, MST ;
Faruqi, AF ;
Giannola, D ;
Irsula, OR ;
Lasken, RS ;
Latterich, M ;
Makarov, V ;
Oliphant, A ;
Pinter, JH ;
Shen, R ;
Sleptsova, I ;
Ziehler, W ;
Lai, E .
GENOME RESEARCH, 2004, 14 (05) :901-907
[4]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[5]   Hepatic and extrahepatic malignancies in primary sclerosing cholangitis [J].
Bergquist, A ;
Ekbom, A ;
Olsson, R ;
Kornfeldt, D ;
Lööf, L ;
Danielsson, Å ;
Hultcrantz, R ;
Lindgren, S ;
Prytz, H ;
Sandberg-Gertzén, H ;
Almer, S ;
Granath, F ;
Broomé, U .
JOURNAL OF HEPATOLOGY, 2002, 36 (03) :321-327
[6]   Increased prevalence of primary sclerosing cholangitis among first-degree relatives [J].
Bergquist, A ;
Lindberg, G ;
Saarinen, S ;
Broomé, U .
JOURNAL OF HEPATOLOGY, 2005, 42 (02) :252-256
[7]   ALPHA-4-BETA-7-INTEGRIN MEDIATES LYMPHOCYTE BINDING TO THE MUCOSAL VASCULAR ADDRESSIN MADCAM-1 [J].
BERLIN, C ;
BERG, EL ;
BRISKIN, MJ ;
ANDREW, DP ;
KILSHAW, PJ ;
HOLZMANN, B ;
WEISSMAN, IL ;
HAMANN, A ;
BUTCHER, EC .
CELL, 1993, 74 (01) :185-195
[8]   Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor α-308 promoter polymorphism [J].
Bittencourt, PL ;
Palacios, SA ;
Cançado, ELR ;
Carrilho, FJ ;
Porta, G ;
Kalil, J ;
Goldberg, AC .
GUT, 2002, 51 (04) :609-610
[9]   Cholangiocarcinoma in primary sclerosing cholangitis:: Risk factors and clinical presentation [J].
Boberg, KM ;
Bergquist, A ;
Mitchell, S ;
Pares, A ;
Rosina, F ;
Broomé, U ;
Chapman, R ;
Fausa, O ;
Egeland, T ;
Rocca, G ;
Schrumpf, E .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (10) :1205-1211
[10]   Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status [J].
Braun, C ;
Zahn, R ;
Martin, K ;
Albert, E ;
Folwaczny, C .
CLINICAL IMMUNOLOGY, 2001, 101 (03) :357-360